ADAP

Adaptimmune Therapeutics Plc

Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Adaptimmune Therapeutics PLC (ADAP) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

7 transactions (past 365 days)

ADAP
CFO
Sale
-$960
Wood Gavin96,000 shares @ $0.01
Filed 2025-09-03Trade 2025-09-02
ADAP
COO
Sale
-$2.1K
Bertrand William C Jr207,000 shares @ $0.01
Filed 2025-08-29Trade 2025-08-28
ADAP
Director
Sale
-$176.1K
Behbahani Ali14,671,794 shares @ $0.01
Filed 2025-08-19Trade 2025-08-18
ADAP
Director
Sale
-$53.1K
Behbahani Ali4,828,206 shares @ $0.01
Filed 2025-08-19Trade 2025-08-15
ADAP
10% Owner
Sale
-$2.8M
Ecor1 Capital, Llc27,433,338 shares @ $0.10
Filed 2025-07-30Trade 2025-07-30
ADAP
10% Owner
Sale
-$271.4K
Ecor1 Capital, Llc2,687,460 shares @ $0.10
Filed 2025-07-30Trade 2025-07-29
ADAP
10% Owner
Sale
-$3.8M
Ecor1 Capital, Llc33,931,740 shares @ $0.11
Filed 2025-07-30Trade 2025-07-28
Cluster Buy Signals →All Insider Signals →Top Insider Buying →